RNase-H-mediated silencing in the CNS proves predictably nontrivial (2022)

First Author: Moazami M
Attributed to:  Antisense Oligonucleotide Therapy for Neuromuscular Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.medj.2022.10.004

PubMed Identifier: 36370693

Publication URI: http://europepmc.org/abstract/MED/36370693

Type: Journal Article/Review

Parent Publication: Med

Issue: 11

ISSN: 2666-6340